Board of Directors

Anatoly Chubays,
Chairman of the Executive Board of RUSNANO Management Company LLC                            

Yuri Udaltsov, 
Deputy Chairman of the Executive Board of RUSNANO Management Company LLC                            

Vladimir Avetissian, 
Deputy Chairman of the Executive Board of RUSNANO Management Company LLC                            

Leonid Melamed,
Chairman of the Board of Directors of Team Drive LLC

Olga Shpichko,
Managing director for investment activity of RUSNANO Management Company LLC                            

Pavel Rodyukov,
Investment Director of RUSNANO Management Company LLC                            

Vladimir Gurdus,
CEO of RMI Partners LLC

All Partners

All Portfolio

MEDIA CENTER

  • Pfizer and NovaMedica Complete Strategic Partnership Agreement for the Technology Transfer of 30 Key Medicines

    Pfizer and NovaMedica Complete Strategic Partnership Agreement for the Technology Transfer of 30 Key Medicines

    Pfizer Inc, one of the world’s premier biopharmaceutical companies and NovaMedica, a Russian pharmaceutical company established by Rusnano and Domain Associates, have completed the last stage of negotiations for a long-term strategic partnership designed to transfer the rights and technologies for the production of more than 30 life-saving and essential drugs from the Pfizer product portfolio. The deal will enable Pfizer and NovaMedica to improve the health of patients in Russia and modernize the Russian pharmaceutical industry.

All news